ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1187

Smoking Status Is Associated with Inflammatory Cytokine Profile and Disease Activity in Anti-Citrullinated Protein Antibody Positive Rheumatoid Arthritis: Decreased Inflammation and Disease Improvement with Smoking Cessation?

Catriona Cramb1, Jeremy Sokolove2, Geoffrey M. Thiele3, Gail S. Kerr4, Grant W. Cannon5, Andreas M. Reimold6, Ted R. Mikuls7 and William H. Robinson8, 1VA Palo Alto Heatlh Care System and Stanford University, Palo Alto, CA, 2Medicine, VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, 3Int Med/Sec of Rheum/Immun, Univ of Nebraska Med Ctr, Omaha, NE, 4Rheumatology, Washington DC VAMC, Georgetown and Howard University, Washington, DC, 5Division of Rheumatology, Salt Lake City VA and University of Utah, Salt Lake City, UT, 6Rheumatology, Dallas VA and University of Texas Southwestern, Dallas, TX, 7Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 8Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: anti-citrullinated protein/peptide antibodies (ACPA), cytokines, pathogenesis and tobacco use, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumamtoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Smoking is a major risk factor for rheumatoid arthritis (RA) and has been associated with increased disease severity and lower rates disease remission.   We hypothesized that levels of disease activity would be associated with smoking status and this would be related to levels of anti-citrullinated protein antibodies (ACPA) and/or serum cytokines.

Methods:   The Veterans Affairs RA (VARA) registry was initiated in 2003 with routine collection of clinical demographics including disease activity score (DAS28) as well as baseline serum sampling.  1468 veterans with RA were included in the current study (76.9% anti-CCP2+, 90.7% male, mean age median age 63 (IQR 57-72), Median disease duration 8.45 years (IQR 2.8-18).  Baseline serum samples were evaluated for levels of 19 distinct ACPA and 17 cytokines using the BioPlex platform on the Luminex 200 instrument.  Smoking status was recorded as current, former, or never smokers.  We evaluated the association of smoking status with disease activity (DAS28) by ANOVA and with levels of ACPA and cytokines using significance analysis of microarray (SAM) and output sorted based on false discovery rates (FRDs) in order to identify cytokines or autoantibodies with the greatest difference between different categories of smoking status.

Results:   RA disease activity was significantly higher among current compared with former or never smokers (P<0.01).  Among anti-CCP2 positive patients, levels of several cytokines associated with RA pathogenesis including TNFα, IL-17, IFNγ, GM-CSF, MCP-1, IL-2, and IL-7 were found to be significantly higher among current smokers compared with both former and non-smokers (FDR  (q-value) <0.1%).  Cytokine levels were similar between former and never smokers.  Notably, levels of many ACPA were higher among current compared with never smokers, but similar between current and former smokers.  Though number of subjects was smaller, the effect of smoking status on cytokine profile was not observed in the anti-CCP2 negative population.

Conclusion:   Among anti-CCP2 positive RA patients, current smoking status is strongly associated with increased RA disease activity as well as elevation in several serum cytokines.  This effect does not seem to be related to level of ACPA.  The observation that higher levels of DAS28 and serum cytokines was only seen in current, and not former, smokers suggests that  the effect of smoking may be minimized by smoking cessation.  The effect of smoking cessation on RA disease activity should be evaluated in a prospective manner and multiplex cytokine profiling may provide a surrogate endpoint for efficacy of this intervention.


Disclosure:

C. Cramb,
None;

J. Sokolove,
None;

G. M. Thiele,
None;

G. S. Kerr,
None;

G. W. Cannon,
None;

A. M. Reimold,
None;

T. R. Mikuls,
None;

W. H. Robinson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/smoking-status-is-associated-with-inflammatory-cytokine-profile-and-disease-activity-in-anti-citrullinated-protein-antibody-positive-rheumatoid-arthritis-decreased-inflammation-and-disease-improvemen/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology